Jeffrey Harter
Optometrist · Raytown, MONPI 1831326339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Alcon at 25.5% of the total.
Across 113 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$817
- Coopervision Inc.$482
- Johnson & Johnson Vision Care, Inc.$359
- Mallinckrodt Hospital Products Inc.$221
- Bausch & Lomb, A Division Of Bausch Health US, LLC$195
- Novartis$188
- plus $946 from 14 others
Across 8 payments — averaging $14,060 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson Vision Care, Inc.$112K
What the payments were for
- Speaking & faculty fees$2508%
- Food & beverage$2,95892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 27 | $817 |
| Coopervision Inc. | 20 | $482 |
| Johnson & Johnson Vision Care, Inc. | 16 | $359 |
| Mallinckrodt Hospital Products Inc. | 10 | $221 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $195 |
| Novartis | 4 | $188 |
| Tarsus Pharmaceuticals, Inc. | 4 | $120 |
| LKC Technologies, Inc. | 1 | $114 |
| Bausch & Lomb Americas Inc. | 5 | $99 |
| Rxsight Inc | 1 | $96 |
| AbbVie(2 entities) | 2 | $95 |
| Oyster Point Pharma, Inc. | 5 | $93 |
| The Cameron-ehlen Group, Inc. | 1 | $77 |
| Ivantis, Inc | 1 | $62 |
| Glaukos Corporation | 1 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $50 |
| Alcon Research LLC | 2 | $37 |
| ABB Con-cise Optical Group LLC | 1 | $21 |
| Biotissue Holdings Inc. | 1 | $15 |
| Synergeyes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1$250
- Precision 1$250
- Precision7$120
- XIIDRA$120
How this compares
$3,208 in reported general payments places this provider in the 85th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 23 | $35,369 |
| RestasisCyclosporine | 15 | $15,035 |
| VyzultaLatanoprostene Bunod | 12 | $4,984 |
| Latanoprost | 140 | $1,693 |
| Timolol Maleate | 22 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $99 | $40,35335 claims |
| AbbVieRestasis | $95 | $15,03515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,030 optometrist providers in Missouri.
Other optometrist in Raytown
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Sarah HubbardChesterfield$91K
- Ariel CerenzieSaint Louis$76K
- Geoffrey PowellKansas City$55K
- Thomas HobbsSedalia$53K
- Heather WebsterColumbia$52K
- Sean MulqueenyCreve Coeur$45K
- Glen LojkaEllisville$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.